News 2016-08-25
Porton Hosts An Investor Reception, August 25, 2016.
Changshou [Chongqing Metropolitan Region], China, August 25, 2016: Porton proudly hosted a delegation of >50 investment analysts and corporate finance media professionals from the Shenzhen Stock Exchange at its USFDA-inspected production facility in Changshou, The guests were hosted by Porton Vice-Presidents Mr. Richard Tao, Dr. Tim Yu and Mr. Victor Cao and toured the site, which produces and supplies custom drug intermediates and APIs for many of the world’s most well-known and respected pharmaceutical and biotechnology companies.

Others
More
News 2026-07-08
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance

News 2026-07-03
Porton Delivers Dual-Payload ADC IND, Advancing Next-generation Conjugate Drug Development
Porton One-stop Biologics and Conjugates CDMO Platform successfully completed the full-cycle delivery of process development and GMP IND clinical sample manufacturing for a dual-payload ADC.